跳至主要内容
临床试验/IRCT20220727055564N1
IRCT20220727055564N1尚未招募2 期

Evaluation of therapeutic effects of lactocare® probiotic on clinical symptoms, frequency of T cell subsets and expression of HOTAIR and MEG3 genes in patients with type II diabetes in comparison with control group

Zahedan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Having a willingness and informed consent to participate in the study
  • Having clinical symptoms of type 2 diabetes
  • Confirmation of type 2 diabetes based on clinical symptoms and diagnostic tests by a specialist doctor
  • No recent history of inflammatory diseases
  • No history of receiving anti-inflammatory drugs
  • No history of taking corticosteroid drugs
  • Absence of immune system diseases and immune deficiencies

排除标准

  • History of heart diseases including: blood pressure, heart failure, heart attack in the last month
  • History of autoimmune diseases including: type 1 diabetes, multiple sclerosis, MS, lupus erythematosus, various types of vasculitis, rheumatism, Crohn's disease, etc.
  • History of liver diseases including: liver cirrhosis and hepatitis in the past year
  • History of underlying lung diseases such as: asthma, bronchiolitis, respiratory allergies, bronchiectasis, COPD
  • History of organ transplant in the last three months
  • People with a history of alcohol consumption
  • Taking immunosuppressive drugs

研究者

发起方
Zahedan University of Medical Sciences

相似试验